HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:HIMS • US4330001060
16.69 USD
-0.55 (-3.19%)
At close: Feb 11, 2026
16.6508 USD
-0.04 (-0.23%)
After Hours: 2/11/2026, 6:30:00 PM
Taking everything into account, HIMS scores 5 out of 10 in our fundamental rating. HIMS was compared to 102 industry peers in the Health Care Providers & Services industry. HIMS has a medium profitability rating, but doesn't score so well on its financial health evaluation. HIMS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
- In the past year HIMS was profitable.
- In the past year HIMS had a positive cash flow from operations.
- In the past 5 years HIMS reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
- HIMS's Return On Assets of 5.99% is amongst the best of the industry. HIMS outperforms 82.35% of its industry peers.
- The Return On Equity of HIMS (23.03%) is better than 91.18% of its industry peers.
- HIMS has a Return On Invested Capital of 5.84%. This is in the better half of the industry: HIMS outperforms 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 6.05%, HIMS belongs to the best of the industry, outperforming 81.37% of the companies in the same industry.
- HIMS's Operating Margin of 5.96% is fine compared to the rest of the industry. HIMS outperforms 67.65% of its industry peers.
- Looking at the Gross Margin, with a value of 75.01%, HIMS belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
- HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
- The number of shares outstanding for HIMS has been increased compared to 1 year ago.
- HIMS has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- HIMS has an Altman-Z score of 2.74. This is not the best score and indicates that HIMS is in the grey zone with still only limited risk for bankruptcy at the moment.
- HIMS has a Altman-Z score (2.74) which is comparable to the rest of the industry.
- The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
- HIMS's Debt to FCF ratio of 8.13 is in line compared to the rest of the industry. HIMS outperforms 53.92% of its industry peers.
- HIMS has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.67, HIMS is not doing good in the industry: 69.61% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 2.74 |
ROIC/WACC0.66
WACC8.8%
2.3 Liquidity
- HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- HIMS's Current ratio of 1.88 is fine compared to the rest of the industry. HIMS outperforms 77.45% of its industry peers.
- HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- HIMS has a Quick ratio of 1.64. This is in the better half of the industry: HIMS outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
- HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
- The Earnings Per Share has been growing by 60.35% on average over the past years. This is a very strong growth
- Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 78.02%.
- Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
- HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.57% yearly.
- The Revenue is expected to grow by 22.77% on average over the next years. This is a very strong growth
EPS Next Y-11.37%
EPS Next 2Y3.76%
EPS Next 3Y13.74%
EPS Next 5Y28.57%
Revenue Next Year60.27%
Revenue Next 2Y37.46%
Revenue Next 3Y30.81%
Revenue Next 5Y22.77%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 30.91, which means the current valuation is very expensive for HIMS.
- The rest of the industry has a similar Price/Earnings ratio as HIMS.
- When comparing the Price/Earnings ratio of HIMS to the average of the S&P500 Index (28.23), we can say HIMS is valued inline with the index average.
- HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 28.71.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
- HIMS's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.91 | ||
| Fwd PE | 28.71 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS is on the same level as its industry peers.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.8 | ||
| EV/EBITDA | 22.85 |
4.3 Compensation for Growth
- HIMS has a very decent profitability rating, which may justify a higher PE ratio.
- HIMS's earnings are expected to grow with 13.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.51
EPS Next 2Y3.76%
EPS Next 3Y13.74%
5. Dividend
5.1 Amount
- HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
16.69
-0.55 (-3.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)03-02 2026-03-02/amc
Inst Owners94.2%
Inst Owner Change0.02%
Ins Owners5.93%
Ins Owner Change-1.47%
Market Cap3.80B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target43.45 (160.34%)
Short Float %35.26%
Short Ratio4.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-6.36%
PT rev (3m)-12.76%
EPS NQ rev (1m)35.42%
EPS NQ rev (3m)-50.63%
EPS NY rev (1m)1.4%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.91 | ||
| Fwd PE | 28.71 | ||
| P/S | 1.72 | ||
| P/FCF | 31.8 | ||
| P/OCF | 11.69 | ||
| P/B | 6.54 | ||
| P/tB | 29.96 | ||
| EV/EBITDA | 22.85 |
EPS(TTM)0.54
EY3.24%
EPS(NY)0.58
Fwd EY3.48%
FCF(TTM)0.52
FCFY3.14%
OCF(TTM)1.43
OCFY8.56%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)0.51
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 2.74 |
F-Score3
WACC8.8%
ROIC/WACC0.66
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-11.37%
EPS Next 2Y3.76%
EPS Next 3Y13.74%
EPS Next 5Y28.57%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.46%
Revenue Next 3Y30.81%
Revenue Next 5Y22.77%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.58%
EBIT Next 3Y89.54%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 3 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.